appengine.ai

Artificial Intelligence | Machine Learning | Machine Perception Eyenuk | Digital Health and AI Medical Diagnostics Company


Consumer, Diabetic Retinopathy, Telemedicine, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma, Los Angeles, CA, United States

Eyenuk

Artificial Intelligence | Machine Learning | Machine Perception


Eyenuk | Digital Health and AI Medical Diagnostics Company

Eyenuk

Diabetic Retinopathy, Telemedicine, Retinal Diseases, Eye Screening, Macular Degeneration, Glaucoma,


Los Angeles, CA, United States

Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance.

Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases.

 

B2B2C, B2B

26 to 50

Funded

$16.7M

Scaling Up

2010

 
 

Pharmaceuticals and Medical Products
Pharmaceuticals
Medical Devices
Managed Health Care

Predictive Biomarkers
Autonomous Disease Detection

N/A

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing


Medical Image Analysis

Medical Image Analysis

Digital Health

Digital Health

SOA

SOA

MEAN

MEAN

LAMP

LAMP

PyQT

PyQT

Flask

Flask

MVC

MVC


N/A

 

   Hardware


HTML5

HTML5

XML

XML

JSON

JSON

RESTful

RESTful

RDBMS

RDBMS

MySQL

MySQL

C++

C++

C

C

JavaScript

JavaScript

Python

Python

Windows

Windows

Unix

Unix

Linux

Linux


Neural Networks

Neural Networks

 
 

View All

Senior Software Engineer

Los Angeles, California

Software Engineer

Los Angeles, California

 
 

2

1

$6.2 M

Company was founded 2010 and it took almost 11 years (Jul 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

07/20/2021

Funded

$6.2 M

AXA Investment Managers, Global Health Investment Fund (GHIF)

Date : 07/20/2021

Round: Funded

$ Raised: $6.2 M

Investors: AXA Investment Managers, Global Health Investment Fund (GHIF)

 
 
Kaushal Solanki


Kaushal Solanki
CEO

Frank Cheng


Frank Cheng
President

Mads Dall


Mads Dall
Board Of Directors